The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation

Renal transplantation is the definitive therapy for patients suffering from end-stage renal disease. Though there have been significant advances in immunosuppression in these patients, there is still up to 30% acute and subclinical rejection. Current standards employ lab markers of renal function an...

Full description

Bibliographic Details
Main Authors: Michael L. Kueht, Laxmi Priya Dongur, Matthew Cusick, Heather L. Stevenson, Muhammad Mujtaba
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/10/1700
_version_ 1797472151998038016
author Michael L. Kueht
Laxmi Priya Dongur
Matthew Cusick
Heather L. Stevenson
Muhammad Mujtaba
author_facet Michael L. Kueht
Laxmi Priya Dongur
Matthew Cusick
Heather L. Stevenson
Muhammad Mujtaba
author_sort Michael L. Kueht
collection DOAJ
description Renal transplantation is the definitive therapy for patients suffering from end-stage renal disease. Though there have been significant advances in immunosuppression in these patients, there is still up to 30% acute and subclinical rejection. Current standards employ lab markers of renal function and biopsy results for accurate diagnosis. However, donor derived cell-free DNA has been identified as a measurable lab test that may be able to adequately diagnose rejection at early stages, precluding the need for invasive procedures like biopsy. We obtained published data directly from companies that offer ddcfDNA assay tests and additionally conducted a literature review using databases like PUBMED and NIH U.S. National Library of Medicine. We comprehensively compare the most used ddcfDNA assays, delineate their respective limitations, and further explore future directions in the utility of ddcfDNA in renal transplant patients.
first_indexed 2024-03-09T19:58:05Z
format Article
id doaj.art-7dcbd2e420734358952aed2ec3f79426
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T19:58:05Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-7dcbd2e420734358952aed2ec3f794262023-11-24T00:50:35ZengMDPI AGJournal of Personalized Medicine2075-44262022-10-011210170010.3390/jpm12101700The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney TransplantationMichael L. Kueht0Laxmi Priya Dongur1Matthew Cusick2Heather L. Stevenson3Muhammad Mujtaba4Department of Surgery, Multiorgan Transplant and Hepatobiliary Surgery, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Surgery, Multiorgan Transplant and Hepatobiliary Surgery, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, Division of Histocompatibility and Immunogenetics, University of Michigan Medicine, Ann Arbor, MI 48109, USADepartment of Pathology, Transplant Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Medicine, Transplant Nephrology, University of Texas Medical Branch, Galveston, TX 77555, USARenal transplantation is the definitive therapy for patients suffering from end-stage renal disease. Though there have been significant advances in immunosuppression in these patients, there is still up to 30% acute and subclinical rejection. Current standards employ lab markers of renal function and biopsy results for accurate diagnosis. However, donor derived cell-free DNA has been identified as a measurable lab test that may be able to adequately diagnose rejection at early stages, precluding the need for invasive procedures like biopsy. We obtained published data directly from companies that offer ddcfDNA assay tests and additionally conducted a literature review using databases like PUBMED and NIH U.S. National Library of Medicine. We comprehensively compare the most used ddcfDNA assays, delineate their respective limitations, and further explore future directions in the utility of ddcfDNA in renal transplant patients.https://www.mdpi.com/2075-4426/12/10/1700renal transplantationT-cell mediated rejectionantibody-mediated rejectiondo-nor-derived cell-free DNA
spellingShingle Michael L. Kueht
Laxmi Priya Dongur
Matthew Cusick
Heather L. Stevenson
Muhammad Mujtaba
The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
Journal of Personalized Medicine
renal transplantation
T-cell mediated rejection
antibody-mediated rejection
do-nor-derived cell-free DNA
title The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
title_full The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
title_fullStr The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
title_full_unstemmed The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
title_short The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
title_sort current state of donor derived cell free dna use in allograft monitoring in kidney transplantation
topic renal transplantation
T-cell mediated rejection
antibody-mediated rejection
do-nor-derived cell-free DNA
url https://www.mdpi.com/2075-4426/12/10/1700
work_keys_str_mv AT michaellkueht thecurrentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT laxmipriyadongur thecurrentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT matthewcusick thecurrentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT heatherlstevenson thecurrentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT muhammadmujtaba thecurrentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT michaellkueht currentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT laxmipriyadongur currentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT matthewcusick currentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT heatherlstevenson currentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation
AT muhammadmujtaba currentstateofdonorderivedcellfreednauseinallograftmonitoringinkidneytransplantation